
Aravive ARAV
Quartalsbericht 2023-Q3
hinzugefügt 09.11.2023
Aravive Langfristiger Schuldenstrom 2011-2026 | ARAV
Langfristiger Schuldenstrom Jährlich Aravive
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2.2 M | 2.3 M | 2.09 M | 2.39 M | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 2.39 M | 2.09 M | 2.24 M |
Langfristiger Schuldenstrom anderer Aktien in der Pharmaeinzelhändler
| Name | Langfristiger Schuldenstrom | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
FSD Pharma
HUGE
|
103 K | - | 5743.5 % | $ 69.7 M | ||
|
MorphoSys AG
MOR
|
3.63 M | - | 2.43 % | $ 254 M | ||
|
Happiness Biotech Group Limited
HAPP
|
102 K | - | 1.35 % | $ 17.8 M | ||
|
Amphastar Pharmaceuticals
AMPH
|
7.93 M | $ 16.81 | -2.83 % | $ 786 M | ||
|
AgeX Therapeutics
AGE
|
181 K | - | -10.17 % | $ 12.2 K | ||
|
I-Mab
IMAB
|
8.06 M | - | - | $ 866 M | ||
|
AstraZeneca PLC
AZN
|
382 M | - | - | $ 96.9 B | ||
|
Arcturus Therapeutics Holdings
ARCT
|
4.21 M | $ 7.58 | -3.19 % | $ 208 M | ||
|
Athira Pharma
ATHA
|
465 K | - | - | $ 269 M | ||
|
BiondVax Pharmaceuticals Ltd.
BVXV
|
773 K | - | 0.74 % | $ 768 M | ||
|
Galera Therapeutics
GRTX
|
133 K | - | -32.59 % | $ 7.61 M | ||
|
AbCellera Biologics
ABCL
|
5.82 M | $ 4.08 | -7.39 % | $ 1.22 B | ||
|
Autolus Therapeutics plc
AUTL
|
4.56 M | $ 1.61 | 1.26 % | $ 428 M | ||
|
Compugen Ltd.
CGEN
|
768 K | $ 2.77 | -8.75 % | $ 259 M | ||
|
BioNTech SE
BNTX
|
45 M | $ 89.59 | -2.61 % | $ 21.7 B | ||
|
Coherus BioSciences
CHRS
|
1.83 M | $ 1.6 | -2.15 % | $ 187 M | ||
|
Advaxis
ADXS
|
166 K | - | -9.65 % | $ 45.9 M | ||
|
Can-Fite BioPharma Ltd.
CANF
|
56 K | $ 3.43 | -3.65 % | $ 5.65 M | ||
|
Aeterna Zentaris
AEZS
|
215 K | - | 5.93 % | $ 314 M | ||
|
Aeglea BioTherapeutics
AGLE
|
625 K | - | - | $ 1.01 B | ||
|
CureVac N.V.
CVAC
|
3.47 M | - | - | $ 867 M | ||
|
Applied Genetic Technologies Corporation
AGTC
|
1.27 M | - | - | $ 26.5 M | ||
|
AIkido Pharma
AIKI
|
554 K | - | 1.93 % | $ 17.4 M | ||
|
Esperion Therapeutics
ESPR
|
2.1 M | $ 3.13 | 0.16 % | $ 651 M | ||
|
Eton Pharmaceuticals
ETON
|
65 K | $ 30.12 | -1.94 % | $ 810 M | ||
|
Aptose Biosciences
APTO
|
193 K | - | -45.71 % | $ 1.2 M | ||
|
Aptinyx
APTX
|
337 K | - | -39.0 % | $ 4.57 M | ||
|
Akouos
AKUS
|
671 K | - | 0.23 % | $ 488 M | ||
|
Albireo Pharma
ALBO
|
3.08 M | - | -0.23 % | $ 916 M | ||
|
Exelixis
EXEL
|
27.9 M | $ 50.55 | -1.08 % | $ 13.7 B | ||
|
AlloVir
ALVR
|
316 K | - | 4.14 % | $ 49.1 M | ||
|
Allakos
ALLK
|
3.25 M | - | - | $ 28.6 M | ||
|
Arcutis Biotherapeutics
ARQT
|
294 K | $ 21.54 | -0.16 % | $ 2.74 B | ||
|
Allena Pharmaceuticals
ALNA
|
317 K | - | 3.16 % | $ 1.9 M | ||
|
Fortress Biotech
FBIO
|
2.13 M | $ 2.39 | 3.91 % | $ 66.7 M | ||
|
Ampio Pharmaceuticals
AMPE
|
274 K | - | -11.43 % | $ 502 K | ||
|
Applied Molecular Transport
AMTI
|
4.64 M | - | - | $ 10.1 M | ||
|
Alpine Immune Sciences
ALPN
|
756 K | - | - | $ 2.17 B | ||
|
Forte Biosciences
FBRX
|
416 K | $ 23.52 | -1.86 % | $ 305 M | ||
|
Fennec Pharmaceuticals
FENC
|
2 K | $ 10.11 | 9.36 % | $ 289 M | ||
|
Aileron Therapeutics
ALRN
|
48 K | - | 10.36 % | $ 9.8 M |